Order Article Reprints

Toro L, Michea L, Parra-Lucares A, Mendez-Valdes G, Villa E, Bravo I, Pumarino C, Ayala P, Sanhueza ME, Torres R, et al. High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort. Toxins. 2023; 15(2):97. https://doi.org/10.3390/toxins15020097

Toro, Luis, Luis Michea, Alfredo Parra-Lucares, Gabriel Mendez-Valdes, Eduardo Villa, Ignacio Bravo, Catalina Pumarino, Patricia Ayala, María Eugenia Sanhueza, Ruben Torres, and et al. 2023. "High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort" Toxins 15, no. 2: 97. https://doi.org/10.3390/toxins15020097

Toro, L., Michea, L., Parra-Lucares, A., Mendez-Valdes, G., Villa, E., Bravo, I., Pumarino, C., Ayala, P., Sanhueza, M. E., Torres, R., Elgueta, L., Chavez, S., Rojas, V., & Alvo, M. (2023). High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort. Toxins, 15(2), 97. https://doi.org/10.3390/toxins15020097